Browsing: better

We’re launching a $5 million grant program to fund independent research into how AI impacts users’ wellbeing. The program will provide direct funding, access to our models, and technical support to grantees building open- affect those who use them. Grantees will work fully independently, and will publish their work as open-

Parents have become accustomed to managing technology. Phones have screen-time limits. Social media has privacy settings. Video games have age ratings and spending controls. OpenAI’s new ChatGPT for Teens gives families another set of tools: options for Study Hours, Quiet Hours, selected feature controls and limited safety notifications for parents who link their accounts with…

TL;DR: Get lifetime access to six Claude and ChatGPT courses on sale for $29.99 (reg. $174).

SoFi (NASDAQ: SOFI) and Sezzle (NASDAQ: SEZL) are two of the better-known emerging fintech players. SoFi has been around longer, but Sezzle’s explosive returns during the past five years have put it on the map.

Palantir Technologies Inc.PLTR and UiPath Inc. PATH are prominent players in the rapidly expanding market for artificial intelligence-powered software.

ChatGPT is the most well-known AI chatbot around, but Geminihas been gaining popularity for the past few years. Both models are great with text, but we’re in a multimodal world now, and using your camera to help AI identify objects is becoming increasingly common. 

Investors weighing exposure to financial stocks often have to choose between a wide-net sector fund and a narrower, rules-based strategy. The Fidelity MSCI Financials Index ETF (NYSEMKT:FNCL) tracks a broad basket of U.S. financial firms, while the First Trust Nasdaq Bank ETF (NASDAQ:FTXO) takes a more targeted approach to bank stocks, using a liquidity- and…

A campaign goes out. The results come in. They’re good; better than expected. Everyone celebrates (as they should), the numbers make their way into a report or dashboard, and the team moves on to the next campaign.

Healthcare investors are often faced with a choice between companies that generate steady growth across diversified businesses and those positioned to benefit from improving industry conditions. Abbott Laboratories (NYSE:ABT) and Thermo Fisher Scientific (NYSE:TMO) represent those two approaches. Abbott (NYSE:ABT) continues to deliver broad-based growth across diagnostics, medical devices, and nutrition, while Thermo Fisher (NYSE:TMO)…

Retail is entering a “phase of continuance”, a moment where underlying shopper habits have stabilized, and brands can no longer point to volatility as the sole explanation for performance swings. In this environment, customer experience becomes the differentiator: shoppers reward retailers that reduce friction, stay relevant, and deliver consistency across every trip and channel.